Telix Pharmaceuticals | TLX - Assets

Stock Price
12.41
Daily Change
0.02 0.16%
Monthly
18.98%
Yearly
-55.36%
Q1 Forecast
11.05

Telix Pharmaceuticals reported AUD1.16B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Cochlear AUD 2.79B 31.3M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Integral Diagnostics AUD 744.28M 1.52M Jun/2024
Mayne Pharma AUD 1.14B 9.47M Jun/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Mesoblast USD 782.31M 2.38M Dec/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Pacific Edge NZD 34.66M 2.37M Dec/2025
Paradigm Biopharmaceuticals AUD 24.57M 10.79M Jun/2025
Polynovo AUD 108.72M 11.51M Jun/2024
PYC Therapeutics AUD 159.13M 24.15M Dec/2025
Ramsay Health Care AUD 21.7B 777.8M Dec/2025
ResMed USD 8.5B 195.02M Dec/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024